Source:http://linkedlifedata.com/resource/pubmed/id/18049480
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007589,
umls-concept:C0007600,
umls-concept:C0018956,
umls-concept:C0079419,
umls-concept:C0332291,
umls-concept:C0392756,
umls-concept:C0439677,
umls-concept:C1280500,
umls-concept:C1334889,
umls-concept:C1511938,
umls-concept:C1514485,
umls-concept:C1516960,
umls-concept:C1704259,
umls-concept:C1705987,
umls-concept:C1879547
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-1-14
|
pubmed:abstractText |
Signaling mediated by activation of the transmembrane receptor Notch influences cell-fate decisions, differentiation, proliferation, and cell survival. Activated Notch reduces proliferation by altering cell-cycle kinetics and promotes differentiation in hematopoietic progenitor cells. Here, we investigated if the G(1) arrest and differentiation induced by activated mNotch1 are dependent on tumor suppressor p53, a critical mediator of cellular growth arrest. Multipotent wild-type p53-expressing (p53(wt)) and p53-deficient (p53(null)) hematopoietic progenitor cell lines (FDCP-mix) carrying an inducible mNotch1 system were used to investigate the effects of proliferation and differentiation upon mNotch1 signaling. While activated Notch reduced proliferation of p53(wt)-cells, no change was observed in p53(null)-cells. Activated Notch upregulated the p53 target p21(cip/waf) in p53(wt)-cells, but not in p53(null)-cells. Induction of the p21(cip/waf) gene by activated Notch was mediated by increased binding of p53 to p53-binding sites in the p21(cip/waf) promoter and was independent of the canonical RBP-J binding site. Re-expression of p53(wt) in p53(null) cells restored the inhibition of proliferation by activated Notch. Thus, activated Notch inhibits proliferation of multipotent hematopoietic progenitor cells via a p53-dependent pathway. In contrast, myeloid and erythroid differentiation was similarly induced in p53(wt) and p53(null) cells. These data suggest that Notch signaling triggers two distinct pathways, a p53-dependent one leading to a block in proliferation and a p53-independent one promoting differentiation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1350-9047
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
398-407
|
pubmed:meshHeading |
pubmed-meshheading:18049480-Animals,
pubmed-meshheading:18049480-Cell Proliferation,
pubmed-meshheading:18049480-Erythropoiesis,
pubmed-meshheading:18049480-Hematopoietic Stem Cells,
pubmed-meshheading:18049480-Mice,
pubmed-meshheading:18049480-Mice, Mutant Strains,
pubmed-meshheading:18049480-Multipotent Stem Cells,
pubmed-meshheading:18049480-Myelopoiesis,
pubmed-meshheading:18049480-Receptor, Notch1,
pubmed-meshheading:18049480-Signal Transduction,
pubmed-meshheading:18049480-Tumor Suppressor Protein p53
|
pubmed:year |
2008
|
pubmed:articleTitle |
Notch1 activation reduces proliferation in the multipotent hematopoietic progenitor cell line FDCP-mix through a p53-dependent pathway but Notch1 effects on myeloid and erythroid differentiation are independent of p53.
|
pubmed:affiliation |
Department of Biochemistry, Christian-Albrechts-University of Kiel, Olshausenstrasse 40, Kiel, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|